作者: J. Wallenborn , C.E. Angermann
DOI: 10.1007/S00059-013-3886-Z
关键词:
摘要: Heart failure (HF) is highly prevalent and associated with adverse outcomes high costs. Compared the general population, depression up to five times more common in HF patients. Comorbid increases morbidity mortality risk health-care expenditures even further decreases quality of life. Possible, often interrelated, mediators these effects include biological, behavioral, psychosocial factors. Screening instruments such as self-administered PHQ-2 facilitate detection patients at risk. Although antidepressants may improve psychological well-being, no positive on hard clinical endpoints have been demonstrated date.